Table 3 Active treatment at enrolment in the study population
From: Refractory chronic urticaria in adults: clinical characterization and predictors of severity
Variable | Population cohort (n = 61) |
|---|---|
Treatment | |
Non-sedative H1-antihistamines | 100% (n = 61) |
Number of daily doses | |
 4 | 14.8% (n = 9) |
 3 | 13.1% (n = 8) |
 2 | 52.4% (n = 32) |
 1 | 19.7% (n = 12) |
Montelukast | |
 Yes | 13.1% (n = 8) |
Omalizumab | |
 Yes | 6.6% (n = 4) |
Systemic corticotherapy | |
 Yes | 6.6% (n = 4) |
Ciclosporine | |
 Yes | 1.6% (n = 1) |